Hyper Corporation

Hyper Corporation EBIT per Employee

The EBIT per Employee of Hyper Corporation (065650.KQ) as of Nov 5, 2026 is 41.65 M KRW. In the previous year, EBIT per Employee was -30.06 M KRW — a change of -238.55% (higher).

EBIT per Employee

41.65 MKRW

YoY

-238.55%

Last updated:

EBIT per Employee of Hyper Corporation is 2025 41.65 M KRW. EBIT per Employee of Hyper Corporation was 2024 -30.06 M KRW. It decreases by -238.55% higher compared to the previous year.

The Hyper Corporation EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2016
-57.82 M KRW
Jan 1, 2017
-182.83 M KRW
Jan 1, 2018
-93.34 M KRW
Jan 1, 2019
-34.29 M KRW
Jan 1, 2020
-34.36 M KRW
Jan 1, 2022
-205.81 M KRW
Jan 1, 2023
-30.06 M KRW
Jan 1, 2025
41.65 M KRW
The Hyper Corporation EBIT per Employee history
YEAREBIT per EmployeeYoY
41.65 MKRW-238.55%
-30.06 MKRW-85.39%
-205.81 MKRW+498.97%
-34.36 MKRW+0.19%
-34.29 MKRW-63.26%
-93.34 MKRW-48.95%
-182.83 MKRW+216.18%
-57.82 MKRW+203.30%
-19.07 MKRW-59.16%
-46.68 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

EBIT per Employee of Hyper Corporation is 41.65 M KRW in 2025.

EBIT per Employee of Hyper Corporation changed from -30.06 M KRW to 41.65 M KRW, representing a -238.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Hyper Corporation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Hyper Corporation

All Key Metrics — Hyper Corporation